NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
31,521,566
Share change
+13,687
Total reported value
$64,298,755
Put/Call ratio
94%
Price per share
$2.07
Number of holders
84
Value change
+$27,960
Number of buys
1
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q4 2013

As of 31 Dec 2013, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 84 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,521,566 shares. The largest 10 holders included VANGUARD GROUP INC, NOMURA HOLDINGS INC, BlackRock Fund Advisors, WELLINGTON MANAGEMENT CO LLP, COMMERZBANK AKTIENGESELLSCHAFT /FI, State Street Corp, NORTHERN TRUST CORP, BlackRock Institutional Trust Company, N.A., SUSQUEHANNA INTERNATIONAL GROUP, LLP, and Catalyst Capital Advisors LLC. This page lists 84 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.